United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71610-126_7face95a-3ced-4b19-8946-6f57fe7bbb3f
Product NDC
71610-126
Form
CAPSULE
Composition / generic term
Gabapentin
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Marketing category
ANDA
Marketing start / end (source format)
20080131
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 90 CAPSULE in 1 BOTTLE (71610-126-60) · 71610-126-60
  • 180 CAPSULE in 1 BOTTLE (71610-126-80) · 71610-126-80
  • 270 CAPSULE in 1 BOTTLE (71610-126-92) · 71610-126-92

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Gabapentin — United States | Molindra Medicines